-
Something wrong with this record ?
MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links
V. Marini, F. Nikulenkov, P. Samadder, S. Juul, BR. Knudsen, L. Krejci
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
206292/E/17/Z
Wellcome Trust - United Kingdom
NLK
BioMedCentral
from 2003-12-01
BioMedCentral Open Access
from 2003
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2003-11-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Medline Complete (EBSCOhost)
from 2003-11-28
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
Springer Nature OA/Free Journals
from 2003-12-01
- MeSH
- DNA-Binding Proteins * genetics metabolism MeSH
- DNA Topoisomerases, Type I genetics metabolism MeSH
- Endonucleases * genetics metabolism MeSH
- Phosphoric Diester Hydrolases * genetics metabolism MeSH
- DNA Repair MeSH
- DNA Damage MeSH
- Saccharomyces cerevisiae Proteins * genetics metabolism MeSH
- Saccharomyces cerevisiae MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: DNA-protein cross-links (DPCs) are one of the most deleterious DNA lesions, originating from various sources, including enzymatic activity. For instance, topoisomerases, which play a fundamental role in DNA metabolic processes such as replication and transcription, can be trapped and remain covalently bound to DNA in the presence of poisons or nearby DNA damage. Given the complexity of individual DPCs, numerous repair pathways have been described. The protein tyrosyl-DNA phosphodiesterase 1 (Tdp1) has been demonstrated to be responsible for removing topoisomerase 1 (Top1). Nevertheless, studies in budding yeast have indicated that alternative pathways involving Mus81, a structure-specific DNA endonuclease, could also remove Top1 and other DPCs. RESULTS: This study shows that MUS81 can efficiently cleave various DNA substrates modified by fluorescein, streptavidin or proteolytically processed topoisomerase. Furthermore, the inability of MUS81 to cleave substrates bearing native TOP1 suggests that TOP1 must be either dislodged or partially degraded prior to MUS81 cleavage. We demonstrated that MUS81 could cleave a model DPC in nuclear extracts and that depletion of TDP1 in MUS81-KO cells induces sensitivity to the TOP1 poison camptothecin (CPT) and affects cell proliferation. This sensitivity is only partially suppressed by TOP1 depletion, indicating that other DPCs might require the MUS81 activity for cell proliferation. CONCLUSIONS: Our data indicate that MUS81 and TDP1 play independent roles in the repair of CPT-induced lesions, thus representing new therapeutic targets for cancer cell sensitisation in combination with TOP1 inhibitors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011427
- 003
- CZ-PrNML
- 005
- 20230801133033.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12915-023-01614-1 $2 doi
- 035 __
- $a (PubMed)37194054
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Marini, Victoria $u Department of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic $u International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Pekařská 53, Brno, 60200, Czech Republic
- 245 10
- $a MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links / $c V. Marini, F. Nikulenkov, P. Samadder, S. Juul, BR. Knudsen, L. Krejci
- 520 9_
- $a BACKGROUND: DNA-protein cross-links (DPCs) are one of the most deleterious DNA lesions, originating from various sources, including enzymatic activity. For instance, topoisomerases, which play a fundamental role in DNA metabolic processes such as replication and transcription, can be trapped and remain covalently bound to DNA in the presence of poisons or nearby DNA damage. Given the complexity of individual DPCs, numerous repair pathways have been described. The protein tyrosyl-DNA phosphodiesterase 1 (Tdp1) has been demonstrated to be responsible for removing topoisomerase 1 (Top1). Nevertheless, studies in budding yeast have indicated that alternative pathways involving Mus81, a structure-specific DNA endonuclease, could also remove Top1 and other DPCs. RESULTS: This study shows that MUS81 can efficiently cleave various DNA substrates modified by fluorescein, streptavidin or proteolytically processed topoisomerase. Furthermore, the inability of MUS81 to cleave substrates bearing native TOP1 suggests that TOP1 must be either dislodged or partially degraded prior to MUS81 cleavage. We demonstrated that MUS81 could cleave a model DPC in nuclear extracts and that depletion of TDP1 in MUS81-KO cells induces sensitivity to the TOP1 poison camptothecin (CPT) and affects cell proliferation. This sensitivity is only partially suppressed by TOP1 depletion, indicating that other DPCs might require the MUS81 activity for cell proliferation. CONCLUSIONS: Our data indicate that MUS81 and TDP1 play independent roles in the repair of CPT-induced lesions, thus representing new therapeutic targets for cancer cell sensitisation in combination with TOP1 inhibitors.
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a oprava DNA $7 D004260
- 650 12
- $a fosfodiesterasy $x genetika $x metabolismus $7 D010727
- 650 _2
- $a Saccharomyces cerevisiae $7 D012441
- 650 12
- $a Saccharomyces cerevisiae - proteiny $x genetika $x metabolismus $7 D029701
- 650 _2
- $a DNA-topoisomerasy I $x genetika $x metabolismus $7 D004264
- 650 12
- $a DNA vazebné proteiny $x genetika $x metabolismus $7 D004268
- 650 12
- $a endonukleasy $x genetika $x metabolismus $7 D004720
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nikulenkov, Fedor $u Department of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic
- 700 1_
- $a Samadder, Pounami $u Department of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic
- 700 1_
- $a Juul, Sissel $u Department of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, Aarhus, 8000, Denmark
- 700 1_
- $a Knudsen, Birgitta R $u Department of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, Aarhus, 8000, Denmark
- 700 1_
- $a Krejci, Lumir $u Department of Biology, Masaryk University, Kamenice 5/B07, Brno, 62500, Czech Republic. lkrejci@chemi.muni.cz $u International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Pekařská 53, Brno, 60200, Czech Republic. lkrejci@chemi.muni.cz $u National Centre for Biomolecular Research, Masaryk University, Kamenice 5/C04, Brno, 625 00, Czech Republic. lkrejci@chemi.muni.cz $1 https://orcid.org/0000000247321405 $7 xx0125663
- 773 0_
- $w MED00008168 $t BMC biology $x 1741-7007 $g Roč. 21, č. 1 (2023), s. 110
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37194054 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801133030 $b ABA008
- 999 __
- $a ok $b bmc $g 1963689 $s 1197692
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 21 $c 1 $d 110 $e 20230516 $i 1741-7007 $m BMC biology $n BMC Biol $x MED00008168
- GRA __
- $a 206292/E/17/Z $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20230718